INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 109 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $266 | -73.4% | 480 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 480 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 480 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 480 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 480 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 480 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 480 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 480 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 480 | +42.9% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 336 | -3.7% | 0.00% | – |
| Q1 2016 | $2,000 | -89.5% | 349 | -85.1% | 0.00% | – |
| Q4 2015 | $19,000 | +533.3% | 2,337 | +593.5% | 0.00% | – |
| Q3 2015 | $3,000 | -88.5% | 337 | -85.5% | 0.00% | – |
| Q2 2015 | $26,000 | -13.3% | 2,326 | +6.8% | 0.00% | – |
| Q1 2015 | $30,000 | -18.9% | 2,177 | +0.2% | 0.00% | – |
| Q4 2014 | $37,000 | – | 2,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |